181 related articles for article (PubMed ID: 30588253)
1. OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells.
Wang D; Chen Z; Lin F; Wang Z; Gao Q; Xie H; Xiao H; Zhou Y; Zhang F; Ma Y; Mei H; Cai Z; Liu Y; Huang W
J Cancer; 2018; 9(24):4684-4695. PubMed ID: 30588253
[TBL] [Abstract][Full Text] [Related]
2. Opa interacting protein 5 acts as an oncogene in bladder cancer.
He X; Hou J; Ping J; Wen D; He J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
[TBL] [Abstract][Full Text] [Related]
3. Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5.
He X; Ding X; Wen D; Hou J; Ping J; He J
Pathol Res Pract; 2017 Sep; 213(9):1059-1066. PubMed ID: 28843748
[TBL] [Abstract][Full Text] [Related]
4. LncRNA OIP5-AS1 predicts poor prognosis and regulates cell proliferation and apoptosis in bladder cancer.
Wang Y; Shi F; Xia Y; Zhao H
J Cell Biochem; 2019 May; 120(5):7499-7505. PubMed ID: 30485498
[TBL] [Abstract][Full Text] [Related]
5. LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1.
Wu Z; Liu Y; Wei L; Han M
J Surg Res; 2021 Jan; 257():501-510. PubMed ID: 32916503
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation.
Li Y; Xiao F; Li W; Hu P; Xu R; Li J; Li G; Zhu C
Oncol Rep; 2019 Apr; 41(4):2075-2088. PubMed ID: 30816485
[TBL] [Abstract][Full Text] [Related]
7. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model.
Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z
J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p/TRIM14 axis.
Xiao Z; Li J; Jin Q; Liu D
Exp Ther Med; 2021 Apr; 21(4):408. PubMed ID: 33692839
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway.
Meng X; Ma J; Wang B; Wu X; Liu Z
J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498
[TBL] [Abstract][Full Text] [Related]
10. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
[TBL] [Abstract][Full Text] [Related]
11. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
Liang J; Tian XF; Yang W
World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
[TBL] [Abstract][Full Text] [Related]
12. The role of OIP5 in the carcinogenesis and progression of ovarian cancer.
Zhang X; Gu W; Lin A; Duan R; Lian L; Huang Y; Li T; Sun Q
J Ovarian Res; 2023 Sep; 16(1):185. PubMed ID: 37660035
[TBL] [Abstract][Full Text] [Related]
13. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
He J; Zhao Y; Zhao E; Wang X; Dong Z; Chen Y; Yang L; Cui H
Neuro Oncol; 2018 Aug; 20(9):1173-1184. PubMed ID: 29547938
[TBL] [Abstract][Full Text] [Related]
14. Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p.
Yu Q; Li Y; Peng S; Li J; Qin X
Open Med (Wars); 2021; 16(1):512-525. PubMed ID: 33821219
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
16. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis.
Zhi XH; Jiang K; Ma YY; Zhou LQ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
[TBL] [Abstract][Full Text] [Related]
20. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
